Loading clinical trials...
Loading clinical trials...
An Open-Label, Multicenter, Dose Escalation And Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumor Malignancies
Conditions
Interventions
NKTR-214
Locations
3
United States
Investigator Site - New Haven
New Haven, Connecticut, United States
Investigator Site - Portland
Portland, Oregon, United States
Investigator Site - Houston
Houston, Texas, United States
Start Date
December 1, 2015
Primary Completion Date
October 31, 2018
Completion Date
October 31, 2018
Last Updated
July 29, 2021
NCT01137825
NCT02293954
NCT00483366
NCT00875004
NCT02088775
NCT01206465
Lead Sponsor
Nektar Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions